CORDIS
EU research results

CORDIS
English EN

Integrated Imaging in live Cell Analysis (II-LCA), for enhanced development and manufacturing of biologic and cell therapies.

Objective

The successful recruitment and incorporation of an Innovation associate (IA), with expertise in live cell imaging, life sciences instrumentation and automation, into the Valitacell team is integral to the evolution of our technologies. The IA will dramatically enhance Valitacells capabilities in this space, strengthen existing collaborations, and generate further opportunities for future innovation. If successful, II-LCA will lead to the accelerated development of novel biological drugs and cellular therapeutics, for the treatment of diverse disease indications. European patients will benefit from increased access to targeted and innovative breakthrough therapies, through reduced cost of development and improved manufacturing paradigms.

Programme(s)

H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs

Topic(s)

INNOSUP-02-2019-2020 - European SME innovation Associate - pilot

Call for proposal

H2020-INNOSUP-2019-02

See other projects for this call

Funding Scheme

CSA - Coordination and support action
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

VALITACELL LTD

Address

Fosters Ave. - Mount Merrion, Blackrock
V94 Dublin 2

Ireland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 123 746,25

Contact the organisation

Project information

Grant agreement ID: 861845

Status

Grant agreement signed

  • Start date

    15 November 2019

  • End date

    14 November 2020

Funded under:

H2020-EU.2.3.2.2.

  • Overall budget:

    € 123 746,25

  • EU contribution

    € 123 746,25

Coordinated by:

VALITACELL LTD

Ireland

Download

PDF XML

Last update: 12 August 2019

Record number: 224723